3British Committee for Standardization in Haematology, Blood Transfusion Task Force. Guidelines for compatibility procedures in blood transfusion laboratories[J]. Transfus Med, 2004,14 (1) : 59-73.
4Heddle NM,O'Hoski P, Singer J,et al. A prospective study to determine the safety of omitting the antiglobulin erossmatch from pretransfusion testing [J]. Br J Haematol, 1992,81 (4) : 579-584.
5Arslan O. Electronic erossmatching[J]. Transfus Med Rev,2006,20(1) :75-79.
6Kuriyan M ,Fox E. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety [J]. Vox Sang, 2000,78(2) :113-118.
7Kulkarni N, Ali M, Haray PN, et al. Electronic Cross Matching System. Is Routine Pre-Operative Cross Matching of Blood for Colorectal Resections Required Anymore[J]. Endoscopy, 2006,38 (10) : 937-956.
8Judd WJ. Requirements for the electronic crossmatch [J]. Vox Sang, 1998,74(Suppl 2) : 409-417.
9Engelfreit CP, Reesink HW, Krusius T, et al. The use of the computer crossmatch [J]. Vox Sang, 2001, 80 (3):184-192.
10Georgsen J, Jensen F, Jeppesen S, et al. Transfusion service of the county of Funen. Organizational and economical aspects of restructuring [J]. Ugeskr Laeger, 1997,159(12) : 1758-1762.
3Pomper GJ, Rick ME, Epstein JS, et al.Management of severe VWD with cryoprecipitate collected by repeated apheresis of a single dedicated donor[J].Transfusion,2003,43(11):1514.
4Hornsey VS, Krailadsiri P, MacDonald S, et al.Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma[J].Br J Haematol,2000,109(3):665-670.
5Dzik WH. Leukoreducdon of blood component[J].Curr Opin Hema- tol,2002,9(6):521.
6Hellstem P, Muntean W,Schramm W,et al.Practical guidelines for the clinical use of plasma[J].Thromb Res,2002,107(Suppl 1):53-57.
7Mathews V,Srivastava A,Nair SC,et al.Haemostasis with eryoprecipi- tate in patients undergoing surgery forsevere yon Willebrand dis- ease[J].Natl Med J lndia,2000,13(4):188.
8Yamamoto F.Molecular genetics of ABO[J].Vox Sang,2000,78(Suppl 2):91-103.
